Browse > Article

Effects of Ethosuximide on the Pilocarpine Induced Seizure in Rat Model of Neuronal Migration Disorder  

Kim, Byung-Kon (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
Choi, In-Sun (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
Cho, Jin-Hwa (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
Jang, Il-Sung (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
Lee, Maan-Gee (Departments of Pharmacology, College of Medicine, Kyungpook National University)
Choi, Byung-Ju (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
Publication Information
The Korean Journal of Physiology and Pharmacology / v.10, no.5, 2006 , pp. 235-242 More about this Journal
Abstract
Cortical malformation-associated epileptic seizures are resistant to conventional anticonvulsant drugs. Relatively little research has been conducted on the effects of antiepileptic drugs (AEDs) on seizure activity in a rat model of dysplasia. We have used rats exposed to methylazoxymethanol acetate (MAM) in utero, an animal model featuring nodular heterotopia, to investigate the effects of ethosuximide (ETX) in the dysplastic brain. Pilocarpine was used to induce acute seizure in MAM-exposed and age-matched vehicle-injected control animals. Field potential recordings were used to monitor the amplitude and number of population spikes, and paired pulse inhibition in response to stimulation of the commissural pathway. Pharmaco-resistance was tested by measuring seizure latencies after pilocarpine administration (320 mg/kg, Lp.) with and without pre-treatment with ETX. Pre-treatment with 300 mg of ETX significantly prolonged the latency to the status epilepticus (SE) in both control and MAM-treated groups. Pre-treatment with ETX 100mg and ETX 200 mg had little effect in MAMexposed rats. However, ETX 200 mg prolonged the latency to the SE in control groups. Spontaneous field potential and secondary after-discharges were higher for MAM-treated rat in comparison with control rats injects with ETX. The main findings of this study are that acute seizures initiated in MAM-exposed rats are relatively resistant to standard ETX assessed in vivo. These data suggest that ETX do not prolong seizure latencies in MAM-rats exposed to pilocarpine.
Keywords
Ethosuximide; Dysplasia; Methylazoxymethanol acetate; Epilepsy; Pilocarpine;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Bruckner C, Heinemann U. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res 859: 15-20, 2000   DOI   ScienceOn
2 Bruckner C, Stenkamp K, Meierkord H, Heinemann U. Epileptiform discharges induced by combined application of bicuculline and 4-aminopyridine are resistant to standard anticonvulsants in slices of rats. Neurosci Lett 268: 163-165, 1999   DOI   ScienceOn
3 Cavalheiro EA, Santos NF, Priel MR. The pilocarpine model of epilepsy in mice. Epilepsia 37: 1015-1019, 1996   DOI   ScienceOn
4 Glien M, Brandt C, Potschka H, Loscher W. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43: 350-357, 2002   DOI   ScienceOn
5 Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31: 73-84, 1998   DOI   ScienceOn
6 Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50: 105-123, 2002   DOI   ScienceOn
7 Loscher W, Honack D. Profile of UCB L059, A novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 232: 147-158, 1993   DOI
8 Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y. Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 30: 750-757, 1991   DOI   ScienceOn
9 Prayson RA, Estes ML. Cortical dysplasiz: a histopathologic study of 52 cases of partial lobectomy in patients with epilepsy. Hum Pathol 26: 493-500, 1995   DOI   ScienceOn
10 Smyth MD, Barbaro NM, Baraban SC. Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res 50: 251-264, 2002   DOI   ScienceOn
11 Spreafico R, Pasquier B, Minotti L, Garbelli R, Kahane P, Grand S, Benabid A, Tassi L, Avanzini G, Battaglia G, Munari C. Immunocytochemical investigation on dysplastic human tissue from epileptic patients. Epilepsy Res 32: 32-48, 1998
12 Dudek FE, Spitz M. Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J Clin Neurophysiol 14: 90-101, Review 1997   DOI   ScienceOn
13 Castro PA, Pleasure SJ, Baraban SC. Hippocampal heterotopia with molecular and electrophysiological properties of neocortical neurons. Neuroscience 114: 961-972, 2002   DOI   ScienceOn
14 Racine RJ. Modification of seizure activity by electrical stimulation, II: motor seizure. Electroencephalogr Clin Neurophysiol 32: 281- 294, 1972   DOI   ScienceOn
15 Zhu WJ, Roper SN. Reduced inhibition in an animal model of cortical dysplasia. J Neurosci 20(23): 8925-8931, 2000   DOI
16 Chen S, Hillman DE. Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development. Exp Neurol 94: 103-119, 1986   DOI   ScienceOn
17 Chevassus-au-Louis N, Ben-Ari Y, Vergnes M. Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol. Brain Res 812: 252-255, 1998b   DOI
18 Ciaroni S, Cecchini T, Gazzanelli G, Grande PD. Methylazoxymethanol (MAMac) effects on ontogenesis of the mouse neocortex. J Hirnforsch 30: 699-705, 1989
19 Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Loscher W, Lowenstein DH, Moshe SL, Noebels JL, Davis M. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 43: 1410- 1420, 2002
20 Choi IS, Cho JH, Lee MG, Choi BJ. Pilocarpine-induced seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Biol Pharm Bull 28: 1408-1413, 2005   DOI   ScienceOn
21 Hirabayashi S, Binnie CD, Janota I, Polkey CE. Surgical treatment of epilepsy due to cortical dysplasia: clinical and EEG findings. J Neurol Neurosurg Psychiatry 56: 765-770, 1993   DOI   ScienceOn
22 Duncan JS. The promise of new antiepileptic drugs. Br J Clin Pharmacol 53: 123-131, 2002   DOI   ScienceOn
23 Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403, 1985   DOI   ScienceOn
24 Barth PG. Disorders of cerebral migration. Can J Neurol Sci 14: 1-16, 1987   DOI
25 Chevassus-au-Louis N, Congar P, Represa A, Ben-Ari Y, Gaiarsa JL. Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci 95: 10263-10268, 1998a
26 Dudek FE. Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46: 8-14, 2005
27 Fueta Y, Avoli M. Effects of antiepileptic drugs on 4-aminopyridineinduced epileptiform activitity in young and adult rat hippocampus. Epilepsy Res 12: 207-215, 1992,   DOI   ScienceOn
28 Germano IM, Sperber EF. Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res 28; 219-222, 1997
29 Houser CR. Granule cell dispersion in the dentate gyrus of human with temporal lobe epilepsy. Brain Res 535: 195-204, 1990   DOI   ScienceOn
30 Yamaguchi S, Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 11: 9- 16, 1992   DOI   ScienceOn
31 Germano IM, Sperber EF, The effects of neuronal migration disorders on seizure susceptibility. Epilepsia 35(Suppl.8): 137, 1994
32 Babb TL, Ying Z, Hadam J, Penrod C. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 32: 24- 33, 1998   DOI   ScienceOn
33 Mello LM, Cavalhiero EA, Tan AM. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34: 985-995, 1993   DOI   ScienceOn
34 Chen HX, Roper SN. Reduction of spontaneous inhibitory synaptic activity in experimental heterotopic gray matter. J Neurophysiol 89: 150-158, 2003   DOI   ScienceOn
35 Fleck MW, Hirotsune S, Gambello MJ, Phillips-Tansey E, Suares G, Mervis RF, Wynshaw-Boris A, McBain CJ. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J Neurosci 20: 2439-2450, 2000   DOI
36 Germano IM, Zhang YF, Sperber EF, Moshe SL. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia 37: 902-910, 1996   DOI   ScienceOn
37 Amano S, Ihara N, Umeura S. Development of novel rat mutant with spontaneous limbic-like seizures. Am J Pathol 149: 329- 336, 1996
38 Baba A, Okumura S, Mizuo H, Iwata H, The inhibition of diazepam and gamma-aminobutyric acid of depolarization-induced release of [14C] cysteine sulfinate and [3H] glutamate in rat hippocampal slices. J Neurochem 40: 280-284, 1983   DOI
39 Wenzel HJ, Robbins CA, Tsai LH, Schwartzkroin PA. Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. Neurosci Feb 21: 983-998, 2001   DOI
40 Aicardi J. The place of neuronal migration abnormalities in child neurology. Can J Neurol Sci 21: 185-193, Review, 1994   DOI
41 White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44(suppl 7): 2-8, 2003
42 Baraban SC, Schwartzkroin PA. Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment. Epilepsy Res 22: 145-156, 1995   DOI   ScienceOn
43 Calcagnotto ME, Maredes MF, Baraban SC. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 22: 7596-7605, 2002   DOI
44 Sancini G, Franceschetti S, Battaglia G, Colacitti C, Di Luca M, Spreafico R, Avanzini G. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones. Neurosci Lett 246: 181-185, 1998   DOI   ScienceOn
45 de Feo MR, Mecarelli O, Ricci GF. Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate. Pharmacol Res 31: 109-114, 1995
46 Baraban SC, Wenzel HJ, Hochman DW, Schwartzkroin PA. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylaxzoxymethanol in utero. Epilepsy Res 39: 87-102, 2000   DOI   ScienceOn
47 Palmini A. Disorders of cortical development. Curr Opin Neurol 13: 183-192, 2000   DOI   ScienceOn